Belite Bio, Inc
(NASDAQ:BLTE)
$42.41
-0.15 (-0.35%)
Open: 12:56 PM
BLTE Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
BLTE Stock Price Today
Belite Bio, Inc (BLTE) stock declined over -0.35% intraday to trade at $42.41 a share on NASDAQ. The stock opened with a loss of -10.24% at $38.20 and touched an intraday high of $38.20, falling -0.35% against the last close of $42.56. The Belite Bio, Inc in stock market went to a low of $36.15 during the session.
BLTE Stock Snapshot
$42.56
Prev. Close
1.17 Billion
Market Cap
$36.15
Day Low
$38.20
Open
N/A
Number of Shares
$38.20
Day High
N/A
P/E ratio
N/A
EPS (TTM)
N/A
Cash Flow per Share
N/A
Free Float in %
1.91
Book Value
87125.00
Volume
BLTE Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta-1.56
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
Peers
Frequently Asked Questions
What is the current Belite Bio, Inc (BLTE) stock price?
Belite Bio, Inc (NASDAQ: BLTE) stock price is $42.41 in the last trading session. During the trading session, BLTE stock reached the peak price of $38.20 while $36.15 was the lowest point it dropped to. The percentage change in BLTE stock occurred in the recent session was -0.35% while the dollar amount for the price change in BLTE stock was -$0.15.
BLTE's industry and sector of operation?
The NASDAQ listed BLTE is part of Biotechnology industry that operates in the broader Healthcare sector. Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial.
Who are the executives of BLTE?
Ms. Ching-Chen Chiu M.Sc.
Vice President of Clinical Operations
Dr. Yu-Hsin Lin M.B.A., Ph.D.
Chairman of Directors & Chief Executive Officer
Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A.
Chief Financial Officer & Director
Dr. Yu-Hsin Lin M.B.A., Ph.D.
Chairman of Directors & CEO
How BLTE did perform over past 52-week?
BLTE's closing price is 1.30% higher than its 52-week low of $11 where as its distance from 52-week high of $38.6 is -0.38%.
How many employees does BLTE have?
Number of BLTE employees currently stands at N/A. BLTE operates from 5820 Oberlin Drive, San Diego, CA 92121, US.
Link for BLTE official website?
Official Website of BLTE is: https://belitebio.com
How do I contact BLTE?
BLTE could be contacted at phone #858-246-6240 and can also be accessed through its website. BLTE operates from 5820 Oberlin Drive, San Diego, CA 92121, US.
How many shares of BLTE are traded daily?
BLTE stock volume for the day was 87125.00 shares. The average number of BLTE shares traded daily for last 3 months was 121.37 Thousands.
What is the market cap of BLTE currently?
The market value of BLTE currently stands at $1.17 Billion with its latest stock price at $42.41 and N/A of its shares outstanding.